BioCentury | Jun 30, 2020
Product Development

Remdesivir’s price, RWD’s moment & a genomics breakup: a BioCentury Podcast

Gilead has done the biopharma industry a favor by giving remdesivir a Goldilocks price, according to BioCentury Washington Editor Steve Usdin. On the latest edition of the BioCentury This Week podcast , Usdin discusses remdesivir’s price,...
BioCentury | Jun 27, 2020
Deals

Why the WuXi NextCode split makes strategic sense for the multinational genomics company

WuXi NextCode’s move to split its China business from operations in the U.S. and Europe seems like the best path forward for both entities, as each faces tightening regulations that restrict the flow of genomic...
BioCentury | Jun 9, 2020
Finance

Regeneron joins $100M round for DNAnexus to support global growth

Bioinformatics company DNAnexus Inc. raised $100 million in financing to expand its global reach in clinical diagnostic and pharmaceutical markets and medical centers. Perceptive Advisors and Northpond Ventures LLC led the round, joined by new...
BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

Susan Desmond-Hellmann joined VC firm GV as an adviser. She recently joined the board of Pfizer Inc. (NYSE:PFE) after stepping down as CEO of the Bill & Melinda Gates Foundation in December. Previously, she spent...
BC Extra | Jun 11, 2019
Politics & Policy

New China regulations on genetic resources underscore flash point in U.S.-China tensions

Access to genomic data is becoming a flash point in geopolitical tensions between the U.S. and China as both sides are putting in place measures to restrict and scrutinize access to the data. As a...
BC Extra | Jun 11, 2019
Politics & Policy

Senators call for HHS probe into CMS genetic testing payments to Chinese-linked companies

Sens. Charles Grassley (R-Iowa) and Marco Rubio (R-Fla.) have asked the HHS inspector general to investigate payments made by CMS to U.S. genetic testing companies that are partnered with companies that have ties to Beijing....
BC Innovations | Jun 6, 2019
Emerging Company Profile

Scipher: decoding drug response from protein interactions

To improve the accuracy of therapeutic response predictions, Scipher has incorporated protein-protein interaction maps into its machine learning-based analyses of patient gene expression data to spotlight pathologically relevant markers. According to Scipher Medicine Corp. CEO...
BC Week In Review | Feb 8, 2019
Financial News

DNAnexus raises $68M to advance its bioinformatics platform

DNAnexus Inc. (Mountain View, Calif.) raised $68 million in a financing that will enable the bioinformatics company to advance its DNAnexus Apollo platform. DNAnexus launched the cloud-based platform in October. It provides users access to...
BC Extra | Feb 6, 2019
Financial News

DNAnexus raises $68M to advance its bioinformatics platform

DNAnexus Inc. (Mountain View, Calif.) raised $68 million in a financing that will enable the bioinformatics company to advance its DNAnexus Apollo platform. DNAnexus launched the cloud-based platform in October. It provides users access to...
BC Week In Review | Dec 14, 2018
Financial News

WuXi AppTec unchanged in first day of trading on Hong Kong exchange

Shares of WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) were unchanged in the first day of trading in Hong Kong Dec. 13, closing at HK$68. WuXi AppTec priced the offering at HK$68, near the middle of...
Items per page:
1 - 10 of 60
BioCentury | Jun 30, 2020
Product Development

Remdesivir’s price, RWD’s moment & a genomics breakup: a BioCentury Podcast

Gilead has done the biopharma industry a favor by giving remdesivir a Goldilocks price, according to BioCentury Washington Editor Steve Usdin. On the latest edition of the BioCentury This Week podcast , Usdin discusses remdesivir’s price,...
BioCentury | Jun 27, 2020
Deals

Why the WuXi NextCode split makes strategic sense for the multinational genomics company

WuXi NextCode’s move to split its China business from operations in the U.S. and Europe seems like the best path forward for both entities, as each faces tightening regulations that restrict the flow of genomic...
BioCentury | Jun 9, 2020
Finance

Regeneron joins $100M round for DNAnexus to support global growth

Bioinformatics company DNAnexus Inc. raised $100 million in financing to expand its global reach in clinical diagnostic and pharmaceutical markets and medical centers. Perceptive Advisors and Northpond Ventures LLC led the round, joined by new...
BioCentury | Apr 30, 2020
Management Tracks

Desmond-Hellmann joins GV as adviser; plus Radius, Anika, AMAG, AiCure and more

Susan Desmond-Hellmann joined VC firm GV as an adviser. She recently joined the board of Pfizer Inc. (NYSE:PFE) after stepping down as CEO of the Bill & Melinda Gates Foundation in December. Previously, she spent...
BC Extra | Jun 11, 2019
Politics & Policy

New China regulations on genetic resources underscore flash point in U.S.-China tensions

Access to genomic data is becoming a flash point in geopolitical tensions between the U.S. and China as both sides are putting in place measures to restrict and scrutinize access to the data. As a...
BC Extra | Jun 11, 2019
Politics & Policy

Senators call for HHS probe into CMS genetic testing payments to Chinese-linked companies

Sens. Charles Grassley (R-Iowa) and Marco Rubio (R-Fla.) have asked the HHS inspector general to investigate payments made by CMS to U.S. genetic testing companies that are partnered with companies that have ties to Beijing....
BC Innovations | Jun 6, 2019
Emerging Company Profile

Scipher: decoding drug response from protein interactions

To improve the accuracy of therapeutic response predictions, Scipher has incorporated protein-protein interaction maps into its machine learning-based analyses of patient gene expression data to spotlight pathologically relevant markers. According to Scipher Medicine Corp. CEO...
BC Week In Review | Feb 8, 2019
Financial News

DNAnexus raises $68M to advance its bioinformatics platform

DNAnexus Inc. (Mountain View, Calif.) raised $68 million in a financing that will enable the bioinformatics company to advance its DNAnexus Apollo platform. DNAnexus launched the cloud-based platform in October. It provides users access to...
BC Extra | Feb 6, 2019
Financial News

DNAnexus raises $68M to advance its bioinformatics platform

DNAnexus Inc. (Mountain View, Calif.) raised $68 million in a financing that will enable the bioinformatics company to advance its DNAnexus Apollo platform. DNAnexus launched the cloud-based platform in October. It provides users access to...
BC Week In Review | Dec 14, 2018
Financial News

WuXi AppTec unchanged in first day of trading on Hong Kong exchange

Shares of WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) were unchanged in the first day of trading in Hong Kong Dec. 13, closing at HK$68. WuXi AppTec priced the offering at HK$68, near the middle of...
Items per page:
1 - 10 of 60